Welcome to our dedicated page for DSS news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on DSS stock.
DSS, Inc. reports developments across a diversified operating platform that includes Product Packaging, Biotechnology, Commercial Lending, and Securities & Investment Management. Company updates commonly address packaging operations, financial results, balance-sheet actions, common-stock offerings, and regulatory or audit disclosures.
News also covers subsidiary activity such as Sentinel Brokers Company, Inc., a FINRA-registered broker-dealer with fixed income trading, equity market-making, and approval to act as an underwriter and selling group member for corporate securities offerings.
Document Security Systems (DSS) has announced promising in-vitro testing results from its acquisition target, Impact Biomedical, focusing on COVID-19 treatments. The proprietary compounds, Equivir and Linebacker, showed effectiveness in blocking SARS-CoV-2 infection, while 3F Biofragrance functioned as a potent disinfectant. Impact Biomedical's antiviral suite has been valued at $933 million, exceeding previous estimates. The acquisition, set for $50 million in stock, positions DSS to leverage advanced biomedical technologies amid the ongoing pandemic.
Document Security Systems (NYSE American: DSS) announced the completion of a public offering of 1,028,800 shares at $6.25 each, raising approximately $6.43 million before expenses. The raised funds are earmarked for expanding new business lines, acquisitions, and general corporate purposes. Additionally, an underwriter has a 45-day option to purchase up to 154,320 additional shares. The offering was conducted under an effective shelf registration with the SEC, aiming to enhance growth and operational capabilities.
Document Security Systems has priced an underwritten public offering of 1,028,800 shares of common stock at $6.25 per share, generating gross proceeds of $6.43 million before expenses. The funds will support the growth of new business lines, acquisitions, and general corporate needs. Aegis Capital Corp. is managing the offering, expected to close on July 7, 2020. The underwriter has a 45-day option to purchase an additional 154,320 shares to cover over-allotments.
Document Security Systems (DSS) announced the full exercise of the underwriter's over-allotment option for its public offering, resulting in an additional 115,384 shares sold at $7.80 each. This increases total gross proceeds to approximately $6.9 million. The company plans to use these funds for business development, acquisitions, and closing unprofitable operations. The offering was made under an effective registration statement filed with the SEC.
Document Security Systems (DSS) has completed an underwritten public offering, raising $6.0 million through the sale of 769,230 shares at $7.80 per share. The company plans to allocate the net proceeds towards developing new business lines, acquisition opportunities, and covering operational costs associated with unprofitable ventures. Additionally, underwriters have a 45-day option to purchase up to 15% more shares. The offering follows an effective registration statement filed with the SEC.
Summary not available.